115 related articles for article (PubMed ID: 2496949)
1. In vitro activity of ampicillin/sulbactam against enterococci determined by the time-kill method.
D'Amato RF; Mathew A; Hochstein L; Cleri DJ; Johnson J
Diagn Microbiol Infect Dis; 1989; 12(1):9-11. PubMed ID: 2496949
[TBL] [Abstract][Full Text] [Related]
2. Time-kill kinetic studies of ampicillin/sulbactam for beta-lactamase-producing enterococci.
Patterson JE; Farrel P; Zervos MJ
Diagn Microbiol Infect Dis; 1991; 14(6):495-9. PubMed ID: 1802536
[TBL] [Abstract][Full Text] [Related]
3. Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection.
Zinner SH; Gilbert D; Dudley MN
Antimicrob Agents Chemother; 1998 Jan; 42(1):72-7. PubMed ID: 9449263
[TBL] [Abstract][Full Text] [Related]
4. Activity of ampicillin plus sulbactam against beta-lactamase producing enterococci in experimental endocarditis.
Thal LA; Vazquez J; Perri MB; Beckley A; Donabedian S; Kaatz GW; Patterson JE; Zervos MJ
J Antimicrob Chemother; 1993 Jan; 31(1):182-5. PubMed ID: 8444668
[No Abstract] [Full Text] [Related]
5. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
Schick DG; Canawati HN; Montgomerie JZ
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):233-9. PubMed ID: 9458980
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the post-antibiotic effect of Streptococcus faecalis and Streptococcus faecium with ampicillin alone or combined with streptomycin: studies on a novel type of antimicrobial interaction.
Fuursted K
Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):351-4. PubMed ID: 3125717
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of ampicillin or vancomycin in combination with decreasing concentrations of streptomycin against enterococci.
Fuursted K
APMIS; 1988 May; 96(5):395-9. PubMed ID: 3132184
[TBL] [Abstract][Full Text] [Related]
9. Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis.
Patterson JE; Masecar BL; Zervos MJ
Antimicrob Agents Chemother; 1988 Jan; 32(1):122-4. PubMed ID: 3126703
[TBL] [Abstract][Full Text] [Related]
10. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Haemophilus influenzae type b to ampicillin-sulbactam.
Azimi PH; Dunphy MG
Antimicrob Agents Chemother; 1989 Sep; 33(9):1620-1. PubMed ID: 2817860
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of the sulbactam-ampicillin combination.
Sessarego FV; Botta GA; Pesce A; Schito GC
J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
[TBL] [Abstract][Full Text] [Related]
13. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
[TBL] [Abstract][Full Text] [Related]
14. Time-kill profiles of Enterococcus to antibiotics used for intravitreal therapy.
Kowalski RP; Karenchak LM; Warren BB; Eller AW
Ophthalmic Surg Lasers; 1998 Apr; 29(4):295-9. PubMed ID: 9571661
[TBL] [Abstract][Full Text] [Related]
15. The killing effects of cefathiamidine or ampicillin alone and in combination with gentamicin against enterococci.
Chen HY; Williams JD
J Antimicrob Chemother; 1983 Jul; 12(1):19-26. PubMed ID: 6413484
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam.
Mortensen JE; LaRocco M; Himes SL; Inderlied C; Daly JA; Campos JM; Mendelman PM
Diagn Microbiol Infect Dis; 1990; 13(4):341-4. PubMed ID: 2076596
[TBL] [Abstract][Full Text] [Related]
17. In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
Chandrasekar PH; Price S; Levine DP
J Antimicrob Chemother; 1985 Aug; 16(2):179-82. PubMed ID: 2933380
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.
Segreti J; Kapell KS; Trenholme GM
Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
Moittie D; Simonet M; Veron M
Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R
Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
